Related Experiment Videos
Influence of vitamin E on platelet function in humans
1Division of Hematology/Oncology, Memorial Hospital of Rhode Island, Pawtucket 02860.
Journal of the American College of Nutrition
|October 1, 1991
Summary
Vitamin E (alpha-tocopherol) inhibits platelet adhesion in vitro, but not aggregation ex vivo. Dietary vitamin E may help prevent blood clots, especially with other medications.
Area of Science:
- Biochemistry
- Hematology
- Nutritional Science
Background:
- Alpha-tocopherol (vitamin E) is a natural antioxidant.
- In vitro studies suggest vitamin E inhibits platelet aggregation and release.
- This effect was hypothesized to stem from reduced cyclooxygenase activity and lipid peroxide formation.
Purpose of the Study:
- To investigate the in vitro and ex vivo effects of alpha-tocopherol on platelet function.
- To explore the potential role of vitamin E in preventing thromboembolic disease.
Main Methods:
- Platelet aggregation and release assays were performed in vitro.
- Platelet function was assessed in individuals supplemented with alpha-tocopherol (400-1200 IU/day).
- Platelet adhesion was measured in a laminar flow chamber at varying shear rates using alpha-tocopherol-enriched platelets.
Main Results:
- In vitro tests showed alpha-tocopherol inhibited platelet aggregation and release.
- Ex vivo studies revealed no significant reduction in platelet aggregation with dietary supplementation.
- Alpha-tocopherol significantly inhibited platelet adhesion to collagen, fibrinogen, and fibronectin at doses as low as 200 IU/day.
- Adherent platelets showed altered morphology (short, rounded projections) instead of typical pseudopodia.
Conclusions:
- The discrepancy between in vitro and ex vivo findings may be due to attainable vitamin E levels in platelets and plasma.
- Dietary alpha-tocopherol supplementation demonstrates significant inhibitory activity on platelet adhesion.
- Vitamin E may play a role in managing thromboembolic disorders, potentially in combination with antiplatelet agents.